Selena Ciabatti
Papers
1
Total Citations
3
H-Index
1
About
Dr. Selena Ciabatti is a leading researcher in radiation oncology and medical physics, with a primary focus on improving treatment outcomes for prostate cancer patients. Her most notable contribution is the development of the ICAROS Study, a multicenter machine learning-based predictive model for acute toxicity in prostate cancer patients undergoing salvage radiotherapy. This groundbreaking work, published in 2025, has already garnered 3 citations, demonstrating its immediate impact on the field. By integrating advanced machine learning techniques with clinical data, Dr. Ciabatti identified key prognostic factors for gastrointestinal and genitourinary toxicity, enabling more personalized and safer treatment planning. Her research bridges the gap between artificial intelligence and clinical oncology, offering a practical tool to reduce side effects and enhance patient quality of life. Dr. Ciabatti’s work is particularly significant for post-prostatectomy patients, a vulnerable population requiring precise radiotherapy. Her achievements underscore her commitment to translating computational innovations into tangible clinical benefits, making her a rising authority in predictive modeling for cancer care.
Research Focus
Key Achievements
Top Papers
- 1